Janagliflozin

Janagliflozin is orally active and highly selective sodium-glucose cotransporter 2 (SGLT2) inhibitor (IC50=0.0058 μM for SGLT2 and 4.802 μM for SGLT1). Janagliflozin inhibits SGLT2 in the proximal renal tubules, reducing glucose reabsorption and promoting urinary glucose excretion (UGE) to lower blood glucose levels. Janagliflozin is promising for research of type 2 diabetes mellitus.

For research use only. We do not sell to patients.

  • CAS No.: 1800115-22-3
  • Formula: C25H29ClO6
  • Molecular Weight:460.95
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All SGLT Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00